Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Cobleigh, Melody
One or more keywords matched the following items that are connected to
Cobleigh, Melody
Item Type
Name
Concept
Antibodies, Monoclonal
Concept
Antibodies, Monoclonal, Humanized
Academic Article
Is trastuzumab every three weeks ready for prime time?
Academic Article
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer.
Academic Article
A case of herceptin cardiotoxicity.
Academic Article
Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression.
Academic Article
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
Academic Article
Evaluation of clinical outcomes according to HER2 detection by fluorescence in situ hybridization in women with metastatic breast cancer treated with trastuzumab.
Academic Article
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer.
Academic Article
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
Academic Article
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Academic Article
Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.
Academic Article
Prognostic and predictive value of tumor vascular endothelial growth factor gene amplification in metastatic breast cancer treated with paclitaxel with and without bevacizumab; results from ECOG 2100 trial.
Academic Article
Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43.
Academic Article
Population pharmacokinetics of trastuzumab emtansine (T-DM1), a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer: clinical implications of the effect of covariates.
Academic Article
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100.
Academic Article
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease.
Academic Article
First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report.
Academic Article
First-line Herceptin monotherapy in metastatic breast cancer.
Academic Article
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.
Search Criteria
Antibodies